Thank you for your participation. To receive credit for participating in this activity complete the posttest evaluation in its entirety and select the type of credit you would like to receive. Certificates of credit will be sent or emailed to you within 4 weeks of the program. Pharmacists must check the CPE monitor for their credits
Demographic Information:

Question Title

* 1. I am a:

Question Title

* 2. I request the following type of Continuing Education Credit:

Question Title

* 3. How did you hear about this conference:

Question Title

* 4. How many patients with COPD do you treat each week?

Posttest Questions:

Please select the most appropriate response for each of the following questions.

Question Title

* 5. The Rome definition proposal of an exacerbation defines an exacerbation in patients with COPD as an event characterized by dyspnea and/or chronic cough and sputum that worsens over what period?

Question Title

* 6. During an acute exacerbation of COPD, heart rate and respiratory rate both:

Question Title

* 7. A 52-year-old male patient reports reduced exercise tolerance, chronic dyspnea, fatigue, tiredness, and increased time to recover after exercise. These are common symptoms to both COPD and which of the following?

Question Title

* 8. An older male patient that is a former heavy smoker and has clinical features that include increased daily sputum production and an increased number of exacerbations has general and clinical characteristics consistent with which of the following comorbidities?

Question Title

* 9. Small airway abnormality in the form of narrowing and loss of terminal bronchioles may occur in which timeframe relative to emphysematous destruction in COPD?

Question Title

* 10. According to 2007 guidance from the US FDA, the duration of treatment normally required for altering disease progression should be at least which of the following?

Question Title

* 11. Approximately 85% of the world’s population lives in LMICs where access to spirometry is severely constrained. In a 2017 survey in Uganda, spirometry was available in approximately what percentage of study sites?

Question Title

* 12. A 75-year-old female located in an LMIC with lower access to medications reports persistent troublesome COPD symptoms despite inhaled salbutamol. What does the WHO Package of Essential Noncommunicable disease interventions recommend for her treatment?

Question Title

* 13. National guidelines are available in high income countries for all except 1.9% of the population. In Low-to-middle income countries, what percentage of the population is not covered by available national guidelines?

Question Title

* 14. A 55-year-old male patient with COPD, who has weekly exacerbations, utilizes digital technology to track daily symptoms, heart rate, respiratory rate, and blood pressure. This is an example of which of the following?

Question Title

* 15. Studies have shown that telehealth can identify exacerbations defined by changes in which of the following?

Question Title

* 16. A real life study of home-based tele-management in advanced COPD by Vitacca et al found that patients under which age used telehealth more frequently?

Question Title

* 17. The prevalence of COPD in a randomly recruited community control group was 8% compared to what percentage in patients with lung cancer?

Question Title

* 18. In a 2018 study, an odds ratio of 1.28 for a lung cancer diagnosis with each decrease of FEV1/FVC of equal to which of the following?

Question Title

* 19. A 60-year-old woman with a smoking history of >30 pack years who stopped 7 years ago visits your office. Does The National Lung Screening Trial recommend lung cancer screening for this individual?

Question Title

* 20. In a 2020 study comparing postoperative outcomes of patients receiving lung cancer surgery according to GOLD stage, a complication was present in 44.7% of GOLD I patients vs what percentage of GOLD 3?

Evaluation/Satisfaction

Please rate your level of agreement with each of the following by selecting the appropriate rating.

Question Title

* 21. After participating in this educational activity, I am now able to:

  Strongly agree Agree Neutral Disagree Strongly disagree
Define a COPD exacerbation and its characteristic presentation in clinical practice
Describe physiologic changes and blood biomarkers that may signal the onset of a COPD exacerbation
List mimickers of COPD exacerbations and their impact on COPD patient outcomes
Define risk factors for COPD development and progression beyond smoke exposure
Describe the interaction of disappearing airways and vanishing vessels in patients with COPD
Outline how to utilize strategies that attenuate COPD progression with current therapies
Describe gaps in care of COPD in LMICs
List strategies to overcome inconsistent utilization of guidelines and low access to therapeutic treatments for COPD in LMICs
Explain the status of COPD research in LMICs
Describe how to evaluate telehealth devices and methods that are potentially applicable to COPD care
Identify telehealth strategies that may aid in detection of early exacerbations
Convert knowledge of telehealth devices and methods to strategies that aid in at home care of COPD and rehabilitation
Describe pathogenic and mechanistic links in the development of lung cancer and COPD
Discuss how to correlate COPD presence and its severity with risk for lung cancer
List strategies that combines lung cancer screening with COPD and other comorbid condition detection
Discuss the impact of COPD on treatments for lung cancer

Question Title

* 22. Please rate your level of agreement with each of the following by selecting the appropriate rating.

  Strongly agree Agree Neutral Disagree Strongly disagree
The conference met the overall objectives.
The speakers demonstrated expertise in the content area.
Information presented at the conference is relevant to my practice.
My overall competence improved as a result of participating.
The teaching and learning methods were effective.
The learning assessment used for this activity was appropriate.
The presentations were fair, balanced and free from commercial bias.
The faculty for this activity were effective.
The faculty for this activity were knowledgeable.
The content provided a fair and balance coverage of the topic.

Question Title

* 23. Which of the following best describes the impact of this activity on your performance?

Question Title

* 24. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 25. What barriers do you see to making changes in your practice, if any?

Declaration of Credit

Please select the appropriate response below based on your participation in the 2020 International COPD Conference:

Question Title

* 26. I participated in the entire 2021 International COPD Conference and claim:

Question Title

* 27. I participated in only the session(s) selected below and claim the associated number of credits:

Question Title

* 28. Participant Information

Question Title

* 29. Type of Credit:

Question Title

* 30. Date of Birth Required For Pharmacists and MOC Only (MM/DD)

Question Title

* 31. For MOC Credit
ABIM ID

Question Title

* 32. Permission to Share Completion Data with ACCME

Question Title

* 33. For Pharmacists Only
NABP ePID (maximum of 10 digits)

Question Title

* 34. For CRCE Credit Only
AARC Member Number (if applicable)

0 of 34 answered
 

T